Evidence map›Paper›PMID 39391402›Full record

ArticleCureus2024

Addiction Therapeutic Communities in Saudi Arabia: An Evaluation of the Resident Retention Rates and Their Correlation With the Type of Drug Used.

Abdulaziz Alshomrani

Abstract read
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Abdulaziz AlshomraniDepartment of Internal Medicine, College of Medicine, University of Bisha, Bisha, SAU.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLong-term retention is a reliable, well-studied factor associated with enhanced outcomes in addiction therapeutic communities (ATCs). The aim of this study was to estimate resident retention rates of ATCs in Saudi Arabia at three and six months, completion of therapy, and early dropout, and investigate their correlation with the type of drug used and other social variables. MATERIAL AND

methodsThis was a cohort retrospective study and data of all residents admitted to all Saudi ATCs since their establishment in 2000 through September 2014 were collected from their files. There were five Saudi ATCs during the study period. The date of admission, discharge date, socio-demographics, and drug use were reported. Retention rates at three and six months and dropouts in the first week were calculated, and the correlation with the type of drug used was studied using multinomial binary logistic regression analysis.

resultsOut of a total of 2050 files, 2003 were suitable for analysis. All residents were male adults. The retention rate for three and six months was 45% and 28%, respectively, and 8.3% dropped out in the first week. The median duration of stay was 77 days. Unemployment and being a student were associated with the completion of treatment. The type of drug used showed no significant correlation with retention rates or dropouts.

conclusionThree-month retention, treatment completion, and dropout within the first week were reasonable, comparable, and consistent with reported rates worldwide. These rates can be considered an indicator of successful Saudi ATC programs. The type of drug used does not make a difference in retention and dropout rates in the present study, which is in line with the ATC management system that does not view the type of drug as a main treatment outcome modifier.

Indexed as

addiction treatmentdeaddiction dropoutrecoveryrehabilitationretentionsauditherapeutic community

Identifiers

PMID39391402
PMCPMC11464947

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.